Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 45 | 2 | 4 | 0 | €397.95 | €408.36 | 2.615% |
| Exact Sciences | 13 | 0 | 2 | 0 | €51.01 | €82.63 | 61.989% |
| Biogen Inc. | 46 | 1 | 2 | 0 | €209.30 | €294.01 | 40.473% |
| Amgen Inc. | 25 | 0 | 1 | 0 | €286.90 | €297.31 | 3.629% |
| Zoetis Inc. A | 23 | 1 | 1 | 0 | €156.26 | €200.06 | 28.029% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 1 | 0 | €910.00 | €959.41 | 5.430% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.83 | €15.58 | -1.560% |
| Abbott Laboratories | 16 | 0 | 0 | 0 | €97.76 | €116.81 | 19.484% |
| Johnson & Johnson | 32 | 1 | 0 | 0 | €139.92 | €196.74 | 40.606% |
| Pfizer Inc. | 31 | 4 | 0 | 0 | €26.32 | €40.66 | 54.511% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | €74.46 | €102.62 | 37.818% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €53.50 | €78.42 | 46.584% |
| Gilead Sciences Inc | 12 | 1 | 0 | 0 | €62.66 | €86.77 | 38.479% |
| AbbVie Inc. | 21 | 0 | 0 | 0 | €149.38 | €174.43 | 16.772% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.60 | €130.00 | 6.036% |
| Eli Lilly Corp. | 50 | 0 | 0 | 0 | €697.80 | €760.00 | 8.914% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €120.20 | €124.93 | 3.934% |